english.prescrire.org > Prescrire International > N°223 - February 2021

n°223

February 2021

Issue Contents
Editorial

Free  Like any other drug?

p.31

New Products


Ebola vaccine rVSV-Zebov (Ervebo°) in an outbreak of Ebola virus disease

p.33-37
Major reduction in incidence among those at risk for this often-fatal infection

Editors' opinion. Ebola infections: it takes more than an effective vaccine to end an epidemic

p.35

Liraglutide (Victoza°) and type 2 diabetes in children aged 10 years and above

p.38

Cemiplimab (Libtayo°) and cutaneous squamous cell carcinoma

p.39-40

Blinatumomab (Blincyto°) in adults with acute lymphoblastic leukaemia in remission and residual leukaemic cells

p.40-41

Osilodrostat (Isturisa°) and endogenous Cushing syndrome

p.41

INN Common stem: vin-

p.41

Fremanezumab (Ajovy°) and prevention of migraine attacks

p.41

Lipegfilgrastim (Lonquex°): a near copy of peg-filgrastim

p.42

Adverse Effects


Smoking cessation: toxic dose levels of certain drugs

p.43-44

Fluconazole: teratogenic, even with as little as just one 150 mg dose

p.45-46

Pregabalin abuse and dependence: on the increase in Europe and elsewhere

p.46-47

Free  Liposomal forms of drugs: now specified in the brand name, but no improvement to the INN

p.48

Reviews


Deep vein thrombosis and pulmonary embolism

p.49-50
Treatment with warfarin, LMWH or apixaban, depending on the situation

Prescrire's proposals. Deep vein thrombosis or pulmonary embolism: choosing an oral anticoagulant

p.50

Outlook


Free  Towards better patient care: drugs to avoid in 2021

p.51-54

Free  Inset. Main changes in the 2021 update

p.53

Adverse effects: often overlooked in systematic reviews

p.54

Queries and Comments. Towards transparency in the research costs of new drugs

p.55

Masthead


Free  Masthead

p.30

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe